Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma

BACKGROUND: Prothrombin induced by vitamin K absence-II (PIVKA-II) was reported as a diagnosis and prognosis marker for hepatocellular carcinoma (HCC). Although the development of systemic therapies for advanced HCC has been remarkable, the role of PIVKA-II is unclear. This prospective study aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaneko, Shun, Kurosaki, Masayuki, Tsuchiya, Kaoru, Yasui, Yutaka, Hayakawa, Yuka, Inada, Kento, Tanaka, Yuki, Ishido, Shun, Kirino, Sakura, Yamashita, Koji, Nobusawa, Tsubasa, Matsumoto, Hiroaki, Kakegawa, Tatsuya, Higuchi, Mayu, Takaura, Kenta, Tanaka, Shohei, Maeyashiki, Chiaki, Tamaki, Nobuharu, Takahashi, Yuka, Nakanishi, Hiroyuki, Izumi, Namiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912231/
https://www.ncbi.nlm.nih.gov/pubmed/35271670
http://dx.doi.org/10.1371/journal.pone.0265235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912231/
https://www.ncbi.nlm.nih.gov/pubmed/35271670
http://dx.doi.org/10.1371/journal.pone.0265235

Ejemplares similares